Harrow Health, Inc. (HROW): Price and Financial Metrics

HROW POWR Grades

• Quality is the dimension where HROW ranks best; there it ranks ahead of 89.55% of US stocks.
• The strongest trend for HROW is in Value, which has been heading up over the past 52 weeks.
• HROW's current lowest rank is in the Growth metric (where it is better than 33.59% of US stocks).

HROW Stock Summary

• With a year-over-year growth in debt of 215.25%, Harrow Health Inc's debt growth rate surpasses 95.66% of about US stocks.
• Over the past twelve months, HROW has reported earnings growth of -153.41%, putting it ahead of just 13.75% of US stocks in our set.
• Harrow Health Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -20.56%, greater than the shareholder yield of merely 13.47% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to Harrow Health Inc, a group of peers worth examining would be CDXC, HAYN, SREV, NAOV, and KRKR.
• Visit HROW's SEC page to see the company's official filings. To visit the company's web site, go to www.harrowinc.com.

HROW Valuation Summary

• HROW's price/earnings ratio is 40.4; this is 10.68% higher than that of the median Healthcare stock.
• HROW's price/sales ratio has moved NA NA over the prior 151 months.
• HROW's price/earnings ratio has moved up 43.4 over the prior 151 months.

Below are key valuation metrics over time for HROW.

HROW Growth Metrics

• The 3 year price growth rate now stands at 25.47%.
• Its 3 year revenue growth rate is now at 257.4%.
• Its 2 year cash and equivalents growth rate is now at 42.6%.

HROW's revenue has moved up $21,199,000 over the prior 30 months.

The table below shows HROW's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	62.571	10.749	7.054
2021-03-31	52.497	2.658	9.767
2020-12-31	48.871	-1.1	-3.357
2020-09-30	46.88	1.118	-1.849
2020-06-30	45.236	-1.619	-21.956
2020-03-31	50.692	1.876	-24.097

HROW's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• HROW has a Quality Grade of B, ranking ahead of 89.56% of graded US stocks.
• HROW's asset turnover comes in at 0.893 -- ranking 27th of 681 Pharmaceutical Products stocks.
• CGEN, ACOR, and CALA are the stocks whose asset turnover ratios are most correlated with HROW.

The table below shows HROW's key quality metrics over time.